[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bayer AG ($BAYRY) is seeing increased social media attention following a Supreme Court review of the Roundup case, potentially bringing regulatory certainty. Recent posts highlight positive developments in clinical trials and analyst upgrades, alongside discussions of past M&A challenges.
$BAYRY is a decentralized finance protocol focused on providing liquidity and trading services.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +25%
X Year: XXXXXXX +27%
1-Year High: XXXXXX on 2025-11-11
1-Year Low: X on 2025-09-16
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XXX +68%
X Months: XXX -XX%
X Year: XXX +54%
1-Year High: XX on 2025-08-09
1-Year Low: X on 2025-01-26
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $bayry in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XX +53%
X Months: XXX -XXXX%
X Year: XXX +38%
1-Year High: XX on 2025-08-09
1-Year Low: X on 2025-01-26
The most influential creators that mention $bayry in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @MarcJacksonLA | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% +17%
X Month: XXX% +42%
X Months: XXX% +40%
X Year: XXX% +60%
1-Year High: XXX% on 2025-01-02
1-Year Low: XX% on 2024-12-16
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"New positive development for Bayer Pharma: regulator gives 🟢for Eylea 8mg in RVO. This will help to delay Eylea LoE cliff on sales (4% Pharma). $BAYN $BAYRY"
X Link @DuckPond_VR 2025-12-12T14:27Z 1086 followers, XXX engagements
"A few ways to ferret out who $RPID has agreements with/is in discussions with on Growth Direct: $RHHBY $AMGN $NVS Also $ABBV $MRK $BAYRY $TAK $BIIB No $LLY $NVO $PFE or $SNY links.yet 😉"
X Link @Reignots 2025-12-08T20:21Z 1468 followers, 1390 engagements
"Goldman Sachs🏁 $ORIC at an Early-Stage Biotech Designation. $PFE $JNJ TAK OTSKY CGEM Goldman Sachs said in its note: We initiate coverage of ORIC as an Early-Stage Biotech. ORIC Pharmaceuticals is a clinical stage biotechnology company with a pipeline of oncology candidates focused on addressing identified resistance in cancer (Overcoming Resistance in Cancer); its lead programs are currently in Ph1b development in prostate cancer (ORIC-944) and lung cancer (enozertinib) with plans to initiate registrational study in 2026 for both. We view the key debate for ORIC will center on the company's"
X Link @Quantumup1 2025-12-04T16:50Z 3934 followers, 1036 engagements
"#earnings before the open on Wednesday November XX 2025 $CRCL $ARCO $ONON $AUTL $GFS $GILT $HBM $CRMD $INVZ $KOPN $TDG $VLN $FUFU $IHS $LOAR $HUMA $ENLT $RDCM $RMTI $RSKD $SMTI $TME $UCL $EWCZ $FLNG $FTCI $HUYA $HYFM $ICL $BAYRY $CREX $ABEO $ABOS $ACXP $AFCG $ALUR $LOCL $LUCD $LVO $MH $MHH $PERI $PHGE $PRLD $PYPD $DDL $KPLT $LEGN"
X Link @eWhispers 2025-11-11T18:57Z 546.8K followers, 104.2K engagements